These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1403730)

  • 1. Prominent inclusion effect of dimethyl-beta-cyclodextrin on photoisomerization of the thromboxane synthetase inhibitor (E)-4-(1-imidazoylmethyl)cinnamic acid.
    Hirayama F; Utsuki T; Uekama K; Yamasaki M; Harata K
    J Pharm Sci; 1992 Aug; 81(8):817-22. PubMed ID: 1403730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stabilizing and solubilizing effects of sulfobutyl ether beta-cyclodextrin on prostaglandin E1 analogue.
    Uekama K; Hieda Y; Hirayama F; Arima H; Sudoh M; Yagi A; Terashima H
    Pharm Res; 2001 Nov; 18(11):1578-85. PubMed ID: 11758766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solubility and mass and nuclear magnetic resonance spectroscopic studies on interaction of cyclosporin A with dimethyl-alpha- and -beta-cyclodextrins in aqueous solution.
    Miyake K; Hirayama F; Uekama K
    J Pharm Sci; 1999 Jan; 88(1):39-45. PubMed ID: 9874700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative studies of the enhancing effects of cyclodextrins on the solubility and oral bioavailability of tacrolimus in rats.
    Arima H; Yunomae K; Miyake K; Irie T; Hirayama F; Uekama K
    J Pharm Sci; 2001 Jun; 90(6):690-701. PubMed ID: 11357172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of PI3K-Akt-Bad pathway in apoptosis induced by 2,6-di-O-methyl-beta-cyclodextrin, not 2,6-di-O-methyl-alpha-cyclodextrin, through cholesterol depletion from lipid rafts on plasma membranes in cells.
    Motoyama K; Kameyama K; Onodera R; Araki N; Hirayama F; Uekama K; Arima H
    Eur J Pharm Sci; 2009 Oct; 38(3):249-61. PubMed ID: 19664706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inclusion complex of 3,9-bis(N,N-dimethylcarbamoyloxy)-5H-benzofuro[3,2-c]quinoline-6-one (KCA-098) with heptakis(2,6-di-O-methyl)-beta-cyclodextrin: interaction and dissolution properties.
    Yamada T; Imai T; Ouchi K; Otagiri M; Hirayama F; Uekama K
    Chem Pharm Bull (Tokyo); 2000 Sep; 48(9):1264-9. PubMed ID: 10993223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation of heptakis(2,6-di-O-ethyl)-beta-cyclodextrin and its nuclear magnetic resonance spectroscopic characterization.
    Hirayama F; Kurihara M; Horiuchi Y; Utsuki T; Uekama K; Yamasaki M
    Pharm Res; 1993 Feb; 10(2):208-13. PubMed ID: 8384365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heptakis(2,6-di-O-methyl-3-O-acetyl)-beta-cyclodextrin: A water-soluble cyclodextrin derivative with low hemolytic activity.
    Hirayama F; Mieda S; Miyamoto Y; Arima H; Uekama K
    J Pharm Sci; 1999 Oct; 88(10):970-5. PubMed ID: 10514341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible enhancing mechanism of the cutaneous permeation of 4-biphenylylacetic acid by beta-cyclodextrin derivatives in hydrophilic ointment.
    Arima H; Miyaji T; Irie T; Hirayama F; Uekama K
    Chem Pharm Bull (Tokyo); 1996 Mar; 44(3):582-6. PubMed ID: 8882455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spectroscopic characterization of the inclusion complex of a luteinizing hormone-releasing hormone agonist, buserelin acetate, with dimethyl-beta-cyclodextrin.
    Matsubara K; Irie T; Uekama K
    Chem Pharm Bull (Tokyo); 1997 Feb; 45(2):378-83. PubMed ID: 9118452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Release characteristics of endogenous constituents by exposure of small intestine to modified beta-cyclodextrins.
    Tanino T; Ogiso T; Iwaki M; Yamaguchi T; Kakehi K
    Biol Pharm Bull; 1999 Oct; 22(10):1099-105. PubMed ID: 10549863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biquinolino-modified beta-cyclodextrin dimers and their metal complexes as efficient fluorescent sensors for the molecular recognition of steroids.
    Liu Y; Song Y; Chen Y; Li XQ; Ding F; Zhong RQ
    Chemistry; 2004 Aug; 10(15):3685-96. PubMed ID: 15281152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absorption enhancement of polypeptide drugs by cyclodextrins. I. Enhanced rectal absorption of insulin from hollow-type suppositories containing insulin and cyclodextrins in rabbits.
    Watanabe Y; Matsumoto Y; Seki M; Takase M; Matsumoto M
    Chem Pharm Bull (Tokyo); 1992 Nov; 40(11):3042-7. PubMed ID: 1477920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NMR spectroscopic characterization of metoprolol/cyclodextrin complexes in aqueous solution: cavity size dependency.
    Ikeda Y; Hirayama F; Arima H; Uekama K; Yoshitake Y; Harano K
    J Pharm Sci; 2004 Jul; 93(7):1659-71. PubMed ID: 15176056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study on inclusion complexation of maltosyl-beta-cyclodextrin, heptakis(2,6-di-O-methyl)-beta-cyclodextrin and beta-cyclodextrin with fucosterol in aqueous and solid state.
    Acartürk F; Imai T; Saito H; Ishikawa M; Otagiri M
    J Pharm Pharmacol; 1993 Dec; 45(12):1028-32. PubMed ID: 7908969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of the interaction of clobazam with cyclodextrins in solution and in the solid state.
    Nakai Y; el-Said Aboutaleb A; Yamamoto K; Saleh SI; Ahmed MO
    Chem Pharm Bull (Tokyo); 1990 Mar; 38(3):728-32. PubMed ID: 2347015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inclusion complex formation of captopril with alpha- and beta-cyclodextrins in aqueous solution: NMR spectroscopic and molecular dynamic studies.
    Ikeda Y; Motoune S; Matsuoka T; Arima H; Hirayama F; Uekama K
    J Pharm Sci; 2002 Nov; 91(11):2390-8. PubMed ID: 12379924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced rectal absorption and reduced local irritation of the anti-inflammatory drug ethyl 4-biphenylylacetate in rats by complexation with water-soluble beta-cyclodextrin derivatives and formulation as oleaginous suppository.
    Arima H; Kondo T; Irie T; Uekama K
    J Pharm Sci; 1992 Nov; 81(11):1119-25. PubMed ID: 1447717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spectral and molecular modeling studies on the influence of β-cyclodextrin and its derivatives on aripiprazole-human serum albumin binding.
    Yan J; Wu D; Ma X; Wang L; Xu K; Li H
    Carbohydr Polym; 2015 Oct; 131():65-74. PubMed ID: 26256161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of P-glycoprotein to the enhancing effects of dimethyl-beta-cyclodextrin on oral bioavailability of tacrolimus.
    Arima H; Yunomae K; Hirayama F; Uekama K
    J Pharmacol Exp Ther; 2001 May; 297(2):547-55. PubMed ID: 11303042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.